Page results
-
This page provides information about the support you can have with some of your concerns while living with myeloma.
-
UCLH cancer services are closely located in and around University College Hospital, which is a one-minute walk from Warren Street and Euston Square tube stations. It’s a 15-minute walk from London King’s Cross St Pancras and Euston stations, and a few minutes on the Circle Line from Paddington Station.
-
The Acute Stroke Unit (ASU) is the next step of care for stroke patients who come to the Hyper-acute Stroke Unit (HASU) at UCLH.
-
The aim of this page is to give information about how we induce labours.
-
Our general medicine services aim to diagnose and advise patients with a range of medical problems.
-
The autonomic unit provides a comprehensive national tertiary clinical service (combining both investigation and management) for a wide variety of autonomic disorders.
-
Cerebral palsy (CP) is a permanent disorder affecting movement in different parts of the body often accompanied by disturbances of sensation, cognition, communication, perception, behaviour and musculoskeletal problems.
-
All patients will undergo an ultrasound scan, which will be performed by a sonographer.
-
This page provides information for employers, teachers, special needs education coordinators (SENCo) and other professionals who work alongside someone with Galactosaemia.
-
Our endocrinology service provides care for patients with a broad range of endocrine conditions in outpatient clinics, as well as after inpatient endocrine emergencies. It also provides a consultation service for inpatients with endocrine conditions.
File results
-
FOI/2022/0539 - Pharmacological choices made for patients undergoing joint replacement surgery
-
FOI/2022/0557 - Patients treated with Visudyne (verteporfin)
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers